Stock Events

Stock Events

Larimar Therapeutics (LRMR) Q3 2025 Earnings

14AugConfirmed

Q3 2024

Q4 2024

Q2 2025

Q3 2025

-0.48

-0.4

-0.32

-0.24

Details

Expected EPS

-0.480258

Actual EPS

-0.41

Surprise EPS

0.07

Surprise Percent

+14.63%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.41 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.